A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort.

<h4>Purpose</h4> <p>About 60% of ovarian cancers are diagnosed at late stage, when5-year survival is less than 30% in contrast to 90% for local disease. This has prompted search for early detection biomarkers. For initial testing, specimens taken months or years before ovarian canc...

Full description

Bibliographic Details
Main Authors:	Terry, K, Schock, H, Fortner, R, Hüsing, A, Fichorova, R, Yamamoto, H, Vitonis, A, Johnson, T, Overvad, K, Tjønneland, A, Boutron-Ruault, M, Mesrine, S, Severi, G, Dossus, L, Rinaldi, S, Boeing, H, Benetou, V, Lagiou, P, Trichopoulou, A, Krogh, V, Kuhn, E, Panico, S, Bueno-de-Mesquita, H, Onland-Moret, N, Peeters, P, Gram, I, Weiderpass, E, Duell, E, Sanchez, M, Ardanaz, E, Etxezarreta, N, Navarro, C, Idahl, A, Lundin, E, Jirström, K, Manjer, J, Wareham, N, Khaw, K, Smith Byrne, K, Travis, R, Gunter, M, Merritt, M, Riboli, E, Cramer, D, Kaaks, R
Format:	Journal article
Language:	English
Published:	American Association for Cancer Research 2016

A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort.

Similar Items